Akorn Inc, based in New York, NY, was a pharmaceutical company that specialized in a wide range of medical products including buprenorphine, naloxone, and veterinary medications. In February 2023, the company filed for Chapter 7 bankruptcy, leading to the cessation of all operations.
Following the bankruptcy filing, Akorn Inc issued an urgent drug recall notice for various products such as adenosine injection, albuterol sulfate inhalation solution, and pentobarbital sodium injection. Customers were advised to report any complaints or adverse events related to the recalled medications through the provided contact information.
Generated from the website